Financial Disclosure Statement:
Financial Support: Supported by National Institutes of Health, National Cancer Institute (Grant No. U10 CA180899 to Children’s Oncology Group Statistics and Data Center), National Clinical Trials Network Operations Center (Grant U10 CA180886), and St Baldrick’s Foundation.
Conflicts of interest : Keri A. Streby is a consultant for Innervate Radiopharmaceuticals LLC and YmAbs Therapeutics Inc. and Kate Matthay is a consultant for Innervate Radiopharmaceuticals LLC.